Innoviva, Inc. (INVA)
$21.03-0.19%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.6B
- Avg volume
- 774.3K
- Beta
- 0.34
- P/E (TTM)
- 4.32
- Short % float
- 9.96%
- Days to cover
- 11.5
- SI change
- -1.8%
- 1W
- +0.33%
- 1M
- -1.91%
- 3M
- -6.37%
- YTD
- +5.84%
- vs SPY 1W
- +1.52%
- vs SPY 1M
- -5.23%
- vs SPY 3M
- -8.76%
- vs SPY YTD
- -5.92%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CRMDBUYCorMedix Inc.RECOVERYQ 6$8.28+0.98%
- NUTXBUYNutex Health, Inc.RECOVERYQ 19$187.60+0.95%
- PHGBUYKoninklijke Philips N.V.RECOVERYQ 8$27.52+0.36%
- RIGLBUYRigel Pharmaceuticals, Inc.RECOVERYQ 8$45.11-1.70%
- NAGESELLNiagen Bioscience IncRECOVERYQ 11$3.21+0.00%
- QGENBUYQiagen N.V.RECOVERYQ 15$41.78-5.20%
- ANIPSELLANI Pharmaceuticals, Inc.RECOVERYQ 9$74.17-1.57%
- PODDSELLInsulet CorporationRECOVERYQ 17$145.42-1.85%
- PDEXBUYPro-Dex, Inc.BULLQ 13$66.86+1.81%
- ZVRABUYZevra Therapeutics, Inc.RECOVERYQ -7$11.65-1.85%
- VXRTSELLVaxart, Inc.RECOVERYQ 1$0.51-1.92%
- CGENBUYCompugen Ltd.RECOVERYQ 11$2.59-1.15%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHBUYDianthus Therapeutics, Inc.$6.2BBULLQ 4$110.07-0.93%
- ELVNBUYEnliven Therapeutics, Inc.$4.4BBULLQ 15$61.15+2.22%
- RLAYBUYRelay Therapeutics, Inc.$4.3BBULLQ 4$19.76+1.65%
- ATAIBUYAtai Beckley Inc.$2.7BBULLQ -2$7.38+0.00%
- NKTRBUYNektar Therapeutics$2.1BRECOVERYQ 13$73.69-0.45%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.7BRECOVERYQ 18$19.57-0.41%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$104.94+1.26%
- IMTXSELLImmatics N.V.$1.2BCRISISQ 8$8.69-2.69%
- CVACCureVac N.V.$1.0B$4.66
- MDXGBUYMiMedx Group, Inc.$622MRECOVERYQ 7$4.27-1.39%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 40
- VALUE
- 36
- GROWTH
- 71
- GARP
- 16
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC18.0%
REV YoY-
ROE30.0%
EPS YoY-
ROA21.0%
GROSS73
OP37
NET81
[VALUATION]
P/E TTM4.32
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.25
P/FCF-
EV/EBITDA1.52
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E21.87
ALTMAN Z-
CURR RATIO16.01
ND/EBITDA-
BETA0.34
